Sovaldi has been found to be remarkably effective in curing most patients with common forms of hepatitis C in a matter of months. But the clinical success comes at a high price.
Most of us aren't as maleficent as the fairy in "Sleeping Beauty," but we're still apt to spite others, even at risk of harming ourselves. Psychologists are trying to figure out why.
People recover better from serious brain injuries if they've had more formal education, researchers say. They're not sure why book learning promotes cognitive reserve.
A look at the critters that live on money finds about 3,000 types of bacteria. Most are harmless. But researchers found traces of DNA from anthrax and drug-resistant pathogens, too.
The faster people get treatment after suffering a stroke, the less likely they are to be permanently disabled or die. Speeding up hospital procedures helps, studies find. But cost is an issue, too.
The developer of Moxduo says the drug, which combines morphine and oxycodone, would provide faster pain relief. But reviewers say there's not enough evidence that the combination drug is safer.
KHNPeople aren't locked into the plan they chose through the health exchanges if their income changes during the year. But you've got just 60 days to make the switch to a cheaper plan.
The FDA is weighing the pros and cons of a drug that would, for the first time, combine morphine and oxycodone in a single pill. Critics warn that it could launch a new wave of abuse.
Last year a scientist said he'd found a new form of botulinum toxin, and was keeping details secret to keep the recipe from terrorists. But other science and public health labs were shut out, too.
A rash of infections in Saudi Arabia could be a warning signal that the deadly virus has reached a tipping point and is ready to spread out of the Middle East, scientists worry.